Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
Completed
Shire
Phase 1
2008-09-08
The purpose of this study is to determine if taking Vyvanse with Prilosec OTC or Adderall XR
with Prilosec OTC changes how quickly the drug is absorbed into the body and/or changes how
much of the drug is absorbed into the body.
Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD
Completed
Shire
Phase 4
2007-06-28
Assess the efficacy & tolerability of Vyvanse when children aged 6-12 years diagnosed with
ADHD are dosed to optimal effect.
A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)
Completed
Shire
Phase 3
2007-06-13
The primary objective of this study is to assess the time of onset of Vyvanse compared to
placebo, in the analog classroom as measured by the Swanson, Kotkin, Agler, M. Flynn and
Pelham (SKAMP) deportment scale in children (aged 6-12) diagnosed with
Attention-Deficit/Hyperactivity Disorder (ADHD).
NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD
Completed
New River Pharmaceuticals
Phase 2
2004-09-01
The purpose of this study is to assess, in a controlled environment, the efficacy and safety
of NRP104 and Adderall XR compared to placebo in treatment of children, aged 6-12, with ADHD.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
